EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fluorescent Sensing Platforms for Detecting and Imaging the Biomarkers of Alzheimer’s Disease

Xingyun Liu, Yibiao Liu, Qiong Liu iD

Biosensors · 2023

DOI: 10.3390/bios13050515 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biosensors, 2023. Verfasst von Xingyun Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518060, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Innovation Committee, National Key Research and Development Program of China, Longgang District Medical and health science and technology project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is an irreversible neurodegenerative disease with clinical symptoms of memory loss and cognitive impairment. Currently, no effective drug or therapeutic method is available for curing this disease. The major strategy used is to identify and block AD at its initial stage. Thus, early diagnosis is very important for intervention of the disease and assessment of drug efficacy. The gold standards of clinical diagnosis include the measurement of AD biomarkers in cerebrospinal fluid and positron emission tomography imaging of the brain for amyloid-β (Aβ) deposits. However, these methods are difficult to apply to the general screening of a large aging population because of their high cost, radioactivity and inaccessibility. Comparatively, blood sample detection is less invasive and more accessible for the diagnosis of AD. Hence, a variety of assays based on fluorescence analysis, surface-enhanced Raman scattering, electrochemistry, etc., were developed for the detection of AD biomarkers in blood. These methods play significant roles in recognizing asymptomatic AD and predicting the course of the disease. In a clinical setting, the combination of blood biomarker detection with brain imaging may enhance the accuracy of early diagnosis. Fluorescence-sensing techniques can be used not only to detect the levels of biomarkers in blood but also to image biomarkers in the brain in real time due to their low toxicity, high sensitivity and good biocompatibility. In this review, we summarize the newly developed fluorescent sensing platforms and their application in detecting and imaging biomarkers of AD, such as Aβ and tau in the last five years, and discuss their prospects for clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeurodegenerative DiseasesHumansAgedAmyloid beta-PeptidesBrainBiomarkerstau Proteins

Stichwörter der Autor:innen

Alzheimer’s diseasebiomarkersdiagnosis

Substanzen

Amyloid beta-PeptidesBiomarkerstau Proteins

Autor:innen und Institutionen

  • Department of Chemistry, College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518060, China.
  • Longgang District Central Hospital of Shenzhen, Shenzhen 518116, China.
  • Shenzhen-Hong Kong Institute of Brain Science, Shenzhen Fundamental Research Institutions, Shenzhen 518055, China.
  • Shenzhen Key Laboratory of Marine Biotechnology and Ecology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518055, China.

ORCID-Profile: Qiong Liu

Förderung

  • Shenzhen Science and Technology Innovation Committee
  • National Key Research and Development Program of China
  • Longgang District Medical and health science and technology project
  • Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions

Zitieren

APA

Liu, X., Liu, Y., & Liu, Q. (2023). Fluorescent Sensing Platforms for Detecting and Imaging the Biomarkers of Alzheimer’s Disease. Biosensors. https://doi.org/10.3390/bios13050515

Vancouver

Liu X, Liu Y, Liu Q. Fluorescent Sensing Platforms for Detecting and Imaging the Biomarkers of Alzheimer’s Disease. Biosensors. 2023. doi:10.3390/bios13050515

BibTeX
@article{Liu2023,
  author = {Liu, Xingyun and Liu, Yibiao and Liu, Qiong},
  title = {Fluorescent Sensing Platforms for Detecting and Imaging the Biomarkers of Alzheimer’s Disease},
  journal = {Biosensors},
  year = {2023},
  doi = {10.3390/bios13050515}
}
Kostenlos starten →